Andi Masters

In Vivo Targeting Replication Protein A for Cancer Therapy

Navnath S. Gavande, S. Jalal, J. Turchi, 2022, Frontiers in Oncology.

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types

M. Georgiadis, C. Hamdouchi, M. Fishel, 2024, Pharmacological research.